Relievant Medsystems said today that it raised a $36 million equity round to support clinical trials for its Intracept intraosseous nerve ablation system. The Intracept system is designed to use radio frequency energy delivered through specially designed instruments during a minimally invasive surgical procedure to access and ablate the basivertebral nerve. The company touts the system as […]
Funding Roundup
Synaptive Medical raises $3.7m
Synaptive Medical last week told the U.S. Securities & Exchange Commission that it raised $3.7 million in an equity round. Toronto-based Synaptive, which makes brain imaging products, did not respond to requests for comment from Massdevice.com on the funding. Eighteen unnamed investors participated in the round, which began last month, according to the filing. In addition to […]
iRhythm Technologies sets terms for $75m IPO
iRhythm Technologies last week set the terms on its forthcoming initial public offering, saying it plans to float 5.35 million shares priced between $13.00 and $15.00 apiece. At the midpoint, the IPO would fetch $74.9 million. San Francisco-based iRhythm has said it plans to use the proceeds to expand the commercial and clinical footprint of its Zio wearable cardiac […]
BioVentures Investors closes $87m Fund IV
BioVentures Investors said today that it closed its 4th medtech fund with $87 million on hand. The Wellesley, Mass.-based venture capital shop said it’s already made 4 investments from its Fund IV, including Eli Lilly (NYSE:LLY) acquisition Locemia Solutions. The other investments were in Deep Vein Medical, which is expected to put its prosthetic venous valve into clinical trials […]
Harbor MedTech raises $5m for regenerative soft tissue repair tech
Harbor MedTech said yesterday that it raised nearly $5 million for the regenerative treatments for soft tissue repair it developed. The Irvine, Calif.-based company said 3 unnamed investors participated in the equity round, which aims to raise a total of nearly $8.5 million, according to a regulatory filing. Harbor developed a technique it calls “Bridge” to […]
Obalon Therapeutics prices $75m IPO
Obalon Therapeutics yesterday priced its initial public offering at $75 million, in line with the range it set last month. The weight loss device maker said it plans to float 5 million shares at $15 apiece, trading on the NASDAQ exchange under the “OBLN” symbol. Carlsbad, Calif.-based Obalon won pre-market approval from the FDA last month for its ingestible, gas-filled […]
AngioSoma taps La Jolla Capital for Liprostin JV
AngioSoma (OTCQB:SOAN) said today that it landed a joint venture with La Jolla Capital to help fund and manage phase III trials studying its flagship product, Liprostin. The Montgomery, Texas-based company has completed 1 phase I and 3 phase II clinical trials evaluating its lead pharmaceutical candidate. Liprostin is a liposomal encapsulated prostaglandin, developed to […]
Enable Injections lands $30m Series A for large-volume injector
Enable Injections Inc. said today that it closed a $30 million Series A round to bring its large-volume injector to market. The Cincinnati, Ohio-based company’s Enable Injector adheres to a patient’s body and delivers biologic doses as large as 50 milliliters. It can be used at work or at home, providing an alternative to costly […]
QuiO raises $1m for smart injection device
QuiO said last week that it closed a $1.05 million seed round led by undisclosed investors to finish developing its smart injection device, prep for pilot studies and a 510(k) submission. The New York-based company is developing smart injection devices and software to monitor patient adherence to clinical trial and daily regimens. Average adherence rates […]
ConvaTec IPO could fetch nearly $2B
ConvaTec said today that it plans to raise about $1.8 billion in an initial public offering on the London Stock Exchange in the largest U.K. flotation this year, even as Great Britain prepares to exit the European Union. The Danish wound dressing and colostomy supply maker, which is owned by private equity firms Avista Capital Partners and Nordic Capital, […]
SQZ Biotech lands $16m in Series B for cell therapy tech
SQZ Biotech said today that it closed a $16 million Series B round to fund its preclinical cell therapy programs for oncology and other undisclosed diseases. NanoDimension and Polaris Partners led the funding for the Boston, Mass.-based biotech startup. SQZ said it developed a microchip that can open immune cell membranes temporarily and let proteins in that […]